Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00933101 · ClinicalTrials.gov registry record
Vascular Inflammation in Adolescents With Type 1 Diabetes
A clinical trial, sponsored by Children's Mercy Hospital Kansas City.
- Completed
- Registry status
- 51
- Enrollment target
NCT00933101: Completed study, sponsored by Children's Mercy Hospital Kansas City.
NCT00933101 is a clinical trial that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 51 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00933101 has completed, sponsored by Children's Mercy Hospital Kansas City.
- COMPLETED
- Registry status
- 51 participants
- Enrollment target
Study Summary
The purpose of this study is to find out if diabetes damages the blood vessels of adolescents with good diabetes control compared to adolescents with less optimal control.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2010-01 |
| Est. Completion | 2011-06 |
What the finished NCT00933101 record still lists
NCT00933101 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 51 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00933101 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00933101 about?
NCT00933101 is a clinical study titled "Vascular Inflammation in Adolescents With Type 1 Diabetes". The purpose of this study is to find out if diabetes damages the blood vessels of adolescents with good diabetes control compared to adolescents with less optimal control.
What is the current status of trial NCT00933101?
This trial is currently completed. The enrollment target is 51 participants. The study started on 2010-01. Estimated completion is 2011-06.
Who is sponsoring clinical trial NCT00933101?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia